New hope for Tough-to-Treat blood cancer patients in major drug trial
NCT ID NCT04501120
Summary
This study is testing the safety and dosing of a new oral drug called lisaftoclax, both by itself and combined with other cancer drugs, for people with acute myeloid leukemia (AML) that has returned or not responded to prior treatment. The goal is to find the safest and most effective dose to control the disease. Researchers will also measure how the drug works in the body and if it helps patients live longer or without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOID MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chongqing University Cancer Hospital
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, China
Contact
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510080, China
Contact
-
Henan Tumor Hospital
RECRUITINGZhengzhou, Henan, China
Contact
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
-
Shanghai The Sixth People' s Hospital
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, China
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guandong, China
Contact
-
The First affiliated hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, China
Contact
-
Union Hospital medical college Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
Contact
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610044, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangya Hospital Central South University
RECRUITINGChangsha, Hunan, China
Contact
Contact
-
Zhongnan Hospital of Hunan university
RECRUITINGWuhan, Hubei, 430071, China
Contact
Contact
-
the First Affiliated Hospital, College of Medicine, Zhejiang University
RECRUITINGHangzhou, Zhejiang, 310003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.